EcoDrugPlus

Fyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSBGRG00000012279
Gene Symbol: FYN
1 Cross references
264 Possible Orthologues:

G Protein-Coupled Receptor 119

Ensembl ID : ENSBGRG00000025718
Gene Symbol: GPR119
1 Cross references
176 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSBGRG00000017279
Gene Symbol: HCK
1 Cross references
206 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSBGRG00000013958
Gene Symbol: ITK
1 Cross references
206 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSBGRG00000014206
Gene Symbol: JAK1
1 Cross references
238 Possible Orthologues:

Janus Kinase 2

Ensembl ID : ENSBGRG00000005982
Gene Symbol: JAK2
1 Cross references
265 Possible Orthologues:

Janus Kinase 3

Ensembl ID : ENSBGRG00000026011
Gene Symbol: JAK3
1 Cross references
103 Possible Orthologues:

Kit Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSBGRG00000023915
Gene Symbol: KIT
1 Cross references
211 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSBGRG00000001524
Gene Symbol: KRAS
1 Cross references
203 Possible Orthologues:

Lck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSBGRG00000012273
Gene Symbol: LCK
1 Cross references
120 Possible Orthologues:

Malt1 Paracaspase

Ensembl ID : ENSBGRG00000014428
Gene Symbol: MALT1
1 Cross references
197 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSBGRG00000016090
Gene Symbol: MAPKAPK2
1 Cross references
240 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).